248 related articles for article (PubMed ID: 36587417)
1. The prediction of lymphocyte count and neutrophil count on the efficacy of Xuebijing adjuvant treatment for severe community-acquired pneumonia: A post hoc analysis of a randomized controlled trial.
Zhang C; He H; Chen X; Wei T; Yang C; Bi J; Tang X; Liu J; Zhang D; Chen C; Song Y; Miao C
Phytomedicine; 2023 Feb; 110():154614. PubMed ID: 36587417
[TBL] [Abstract][Full Text] [Related]
2. Weaker Response to XueBiJing Treatment in Severe Community-Acquired Pneumonia Patients With Higher Body Mass Index or Hyperglycemia: A
Song Y; Wang X; Chen C; Wei T; Lang K; Yang D; Song Y
Front Pharmacol; 2022; 13():755536. PubMed ID: 35721170
[No Abstract] [Full Text] [Related]
3. [Evaluation of clinical value of Xuebijing combined with human immunoglobulin in severe and critically ill patients with coronavirus disease 2019].
Chen L; Zhang A; Li Q; Cui Y; Yuan G
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Apr; 33(4):399-404. PubMed ID: 34053480
[TBL] [Abstract][Full Text] [Related]
4. XueBiJing Injection Versus Placebo for Critically Ill Patients With Severe Community-Acquired Pneumonia: A Randomized Controlled Trial.
Song Y; Yao C; Yao Y; Han H; Zhao X; Yu K; Liu L; Xu Y; Liu Z; Zhou Q; Wang Y; Ma Z; Zheng Y; Wu D; Tang Z; Zhang M; Pan S; Chai Y; Song Y; Zhang J; Pan L; Liu Y; Yu H; Yu X; Zhang H; Wang X; Du Z; Wan X; Tang Y; Tian Y; Zhu Y; Wang H; Yan X; Liu Z; Zhang B; Zhong N; Shang H; Bai C
Crit Care Med; 2019 Sep; 47(9):e735-e743. PubMed ID: 31162191
[TBL] [Abstract][Full Text] [Related]
5. Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill.
Zahorec R
Bratisl Lek Listy; 2001; 102(1):5-14. PubMed ID: 11723675
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil count, lymphocyte count and neutrophil-to-lymphocyte ratio in relation to response to adjunctive dexamethasone treatment in community-acquired pneumonia.
Wittermans E; van de Garde EM; Voorn GP; Aldenkamp AF; Janssen R; Grutters JC; Bos WJW;
Eur J Intern Med; 2022 Feb; 96():102-108. PubMed ID: 34782191
[TBL] [Abstract][Full Text] [Related]
7. [Systematic review and sequential analysis of Xuebijing Injection in treatment of systemic inflammatory response syndrome].
Zhao Z; Hu SX; Guan JF; Yi JJ; Zhang ZW; Chen FY; Xu FB
Zhongguo Zhong Yao Za Zhi; 2021 Aug; 46(15):3980-3989. PubMed ID: 34472275
[TBL] [Abstract][Full Text] [Related]
8. [Effect of Xuebijing on inflammatory response and prognosis in patients with septic shock].
Sun R; Liang M; Yang H; Liu Q; Ma N; Wei D; Dong F
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Apr; 32(4):458-462. PubMed ID: 32527353
[TBL] [Abstract][Full Text] [Related]
9. The immunomodulating activity of trimodulin (polyvalent IgM, IgA, IgG solution): a post hoc analysis of the phase II CIGMA trial.
Singer M; Torres A; Heinz CC; Weißmüller S; Staus A; Kistner S; Jakubczyk K; Häder T; Langohr P; Wartenberg-Demand A; Schüttrumpf J; Vincent JL; Welte T
Crit Care; 2023 Nov; 27(1):436. PubMed ID: 37946226
[TBL] [Abstract][Full Text] [Related]
10. [Interpretation of design ideas and implementation process of randomized controlled trial of Xuebijing injection in the treatment of severe community-acquired pneumonia].
Bai C; Yao C; Shang H; Yu X; Yu K; Yao Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Jul; 31(7):811-814. PubMed ID: 31441401
[TBL] [Abstract][Full Text] [Related]
11. Marked Reduction in 28-day Mortality Among Elderly Patients with Severe Community-acquired Pneumonia: Post Hoc Analysis of a Large Randomized Controlled Trial.
Liu Y; Zhang C; Li C; Bai C; Shang H
Clin Interv Aging; 2020; 15():2109-2115. PubMed ID: 33204076
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for ARDS: clinical, physiological and atypical immunodeficiency.
Song M; Liu Y; Lu Z; Luo H; Peng H; Chen P
BMC Pulm Med; 2020 Apr; 20(1):102. PubMed ID: 32326923
[TBL] [Abstract][Full Text] [Related]
13. [A multicenter prospective cohort study of Xuebijing injection in the treatment of severe coronavirus disease 2019].
Liu X; Song Y; Guan W; Qiu H; Du B; Li Y; Liu Y; Shang H; Zhong N; Coronavirus Disease Emergency Project Research Collaboration G
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Jul; 33(7):774-778. PubMed ID: 34412743
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of Xuebijing injection and its influence on immunomodulation in acute exacerbations of chronic obstructive pulmonary disease: study protocol for a randomized controlled trial.
Xie S; Yan P; Yao C; Yan X; Huo Y; Zhang J; Liu S; Feng Z; Shang H; Xie L
Trials; 2019 Feb; 20(1):136. PubMed ID: 30777117
[TBL] [Abstract][Full Text] [Related]
15. [Effect of hypercapnia on the clinical prognosis and severity of infection in patients with severe community-acquired pneumonia].
Liu X; Wen M; Ding H; Chen S; Li Y; Li X; Zeng H
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):564-569. PubMed ID: 32576348
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin Improves Neutrophil Function and Clinical Outcomes in Pneumonia. A Pilot Randomized Controlled Clinical Trial.
Sapey E; Patel JM; Greenwood H; Walton GM; Grudzinska F; Parekh D; Mahida RY; Dancer RCA; Lugg ST; Howells PA; Hazeldine J; Newby P; Scott A; Nightingale P; Hill AT; Thickett DR
Am J Respir Crit Care Med; 2019 Nov; 200(10):1282-1293. PubMed ID: 31206313
[No Abstract] [Full Text] [Related]
17. [Comparative analysis of clinical features between severe coronavirus disease 2019 and severe community acquired pneumonia].
Teng X; Xie Y; Chen D; Yang L; Wu Z; Tian R; Zhou Z; Lyu H; Wang R
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 May; 34(5):485-491. PubMed ID: 35728849
[TBL] [Abstract][Full Text] [Related]
18. [Predictive value of neutrophil to lymphocyte ratio on 28-day mortality of patients with severe pneumonia].
Liang H; Gao Y; Miao C; Song Y; He F
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Jul; 31(7):827-831. PubMed ID: 31441404
[TBL] [Abstract][Full Text] [Related]
19. [Timing of sequential noninvasive mechanical ventilation following early extubation in aged patients with severe community-acquired pneumonia].
Jia W; Wan Q; Xu S; Yang T; Shi Y; Luo X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Mar; 32(3):324-329. PubMed ID: 32385997
[TBL] [Abstract][Full Text] [Related]
20. [Neutrophil-to-lymphocyte ratio as a serum biomarker associated with community acquired pneumonia].
Che-Morales JL; Cortes-Telles A
Rev Med Inst Mex Seguro Soc; 2019 Mar; 56(6):537-543. PubMed ID: 30889342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
